NEW YORK (GenomeWeb) – The American Cancer Society said today that its Cancer Action Network and 32 other healthcare organizations have sent a letter to congressional leaders urging them to update oversight rules for all diagnostic tests, including laboratory-developed tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.